| α4 is highly expressed in carcinogen-transformed human cells and primary human cancers. | |
| | |
MedLine Citation:
|
PMID: 21339737 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
A regulator of the protein phosphatase 2A (PP2A), α4, has been implicated in a variety of functions that regulate many cellular processes. To explore the role of α4 in human cell transformation and tumorigenesis, we show that α4 is highly expressed in human cells transformed by chemical carcinogens including benzo(a)pyrene, aflatoxin B(1), N-methyl-N'-nitro-N-nitrosoguanidine, nickel sulfate and in several hepatic and lung cancer cell lines. In addition, overexpression of α4 was detected in 87.5% (74/80) of primary hepatocellular carcinomas, 84.0% (21/25) of primary lung cancers and 81.8% (9/11) of primary breast cancers, indicating that α4 is ubiquitously highly expressed in human cancer. Functional studies revealed that elevated α4 expression results in an increase in cell proliferation, promotion of cell survival and decreased PP2A-attributable activity. Importantly, ectopic expression of α4 permits non-transformed human embryonic kidney cells (HEKTER) and L02R cells to form tumors in immunodeficient mice. Furthermore, we show that the highly expressed α4 in transformed cells or human tumors is not regulated by DNA hypomethylation. A microRNA, miR-34b, that suppresses the expression of α4 through specific binding to the 3'-untranslated region of α4 is downregulated in transformed or human lung tumors. Taken together, these observations identify that α4 possesses an oncogenic function. Reduction of PP2A activity due to an enhanced α4-PP2A interaction contributes directly to chemical carcinogen-induced tumorigenesis.Oncogene advance online publication, 21 February 2011; doi:10.1038/onc.2011.20. |
| | |
Authors:
|
L-P Chen; Y-D Lai; D-C Li; X-N Zhu; P Yang; W-X Li; W Zhu; J Zhao; X-D Li; Y-M Xiao; Y Zhang; X-M Xing; Q Wang; B Zhang; Y-C Lin; J-L Zeng; S-X Zhang; C-X Liu; Z-F Li; X-W Zeng; Z-N Lin; Z-X Zhuang; W Chen |
Related Documents
:
|
21152867 - A novel recombinant immuno-tbid with a furin site effectively suppresses the growth of ... 21266077 - Microrna-34a is a potent tumor suppressor molecule in vivo in neuroblastoma. 22465547 - Evaluation of the oscar™ system for the production of monoclonal antibodies by cho-k1... 21512417 - Inhibition of task-3 (kcnk9) channel biosynthesis changes cell morphology and decreases... 9863017 - Up-regulation of nuclear pp1alpha and pp1delta in hepatoma cells. 10664177 - The patterns of cell death and of macrophages in the developing forebrain of the tree s... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-2-21 |
Journal Detail:
|
Title: Oncogene Volume: - ISSN: 1476-5594 ISO Abbreviation: - Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-2-22 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8711562 Medline TA: Oncogene Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, Faculty of Preventive Medicine, School of Public Health, Sun Yat-Sen University, Guangzhou, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Anti-proliferative and pro-apoptotic actions of a novel human and mouse ovarian tumor-associated gen...
Next Document: HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents.